Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes

Gut

Volumn 59, Issue 7, 2010, Pages 934-942

  Durand, Tony ^a   Di Liberto, Gaëtana ^a,b   Colman, Hélène ^a   Cammas, Anne ^c   Boni, Sebastien ^a   Marcellin, Patrick ^b   Cahour, Annie ^d   Vagner, Stephan ^c   Féray, Cyrille ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c INSERM   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE;

ADULT; ARTICLE; CELL COMPARTMENTALIZATION; CELL GROWTH; CELL LINE; CELL SPECIFICITY; CELL TYPE; CLINICAL ARTICLE; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; HEPATITIS C; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; LIVER CELL; LIVER CELL CULTURE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION;

EID: 77953983062     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.192088     Document Type: Article

References (32)

1. Muller HM, Kallinowski B, Solbach C, et al. B-lymphocytes are predominantly involved in viral propagation of hepatitis C virus (HCV). Arch Virol Suppl 1994;9:307-16.
2. Muratori L, Gibellini D, Lenzi M, et al. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 1996;88:2768-74. (Pubitemid 26327532)
3. De Vita S, Sansonno D, Dolcetti R, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995;86:1887-92.
4. Sansonno D, De Vita S, Iacobelli AR, et al. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998;160:3594-601.
5. Roque Afonso AM, Jiang J, Penin F, et al. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol 1999;73:9213-21. (Pubitemid 29487076)
6. Lerat H, Shimizu YK, Lemon SM. Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 59 nontranslated region substitutions selected during passage of virus in lymphoblastoid cells. J Virol 2000;74:7024-31.
7. Fournillier A, Freida D, Defrance T, et al. Analysis of B-lymphocyte differentiation in patients infected with hepatitis C virus. J Med Virol 2004;72:566-74.
8. Bare P, Massud I, Parodi C, et al. Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients. J Gen Virol 2005;86:1717-27.
9. Pal S, Sullivan DG, Kim S, et al. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 2006;130:1107-16.
10. Machida K, Cheng KT, Sung VM, et al. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 2006;80:866-74.
11. Lerat H, Berby F, Trabaud MA, et al. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 1996;97:845-51. (Pubitemid 26057104)
12. Laskus T, Radkowski M, Piasek A, et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000;181:442-8.
13. Pham TN, King D, Macparland SA, et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008;134:812-22.
14. Ducoulombier D, Roque-Afonso AM, Di Liberto G, et al. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 2004;39:817-25.
15. Roque-Afonso AM, Ducoulombier D, Di Liberto G, et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005;79:6349-57.
16. Di Liberto G, Roque-Afonso AM, Kara R, et al. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 2006;131:76-84.
17. Herring BL, Page-Shafer K, Tobler LH, et al. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis 2004;190:1396-403.
18. Micallef JM, Macdonald V, Jauncey M, et al. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. J Viral Hepat 2007;14:413-18.
19. Aitken CK, Lewis J, Tracy SL, et al. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 2008;48:1746-52.
20. Laporte J, Bain C, Maurel P, et al. Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 2003;101:52-7.
21. Forton DM, Karayiannis P, Mahmud N, et al. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004;78:5170-83.
22. Laporte J, Malet I, Andrieu T, et al. Comparative analysis of translation efficiencies of hepatitis C virus 59 untranslated regions among intraindividual quasispecies present in chronic infection: opposite behaviors depending on cell type. J Virol 2000;74:10827-33.
23. Stamataki Z, Shannon-Lowe C, Shaw J, et al. Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells. Blood 2009;113:585-93.
24. Boni S, Lavergne JP, Boulant S, et al. Hepatitis C virus core protein acts as a transmodulating factor on internal translation initiation of the viral RNA. J Biol Chem 2005;280:17737-48.
25. Chesne C, Guyomard C, Fautrel A, et al. Viability and function in primary culture of adult hepatocytes from various animal species and human beings after cryopreservation. Hepatology 1993;18:406-14.
26. Costa-Mattioli M, Svitkin Y, Sonenberg N. LA autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro. Mol Cell Biol 2004;24:6861-70.
27. Bert AG, Grepin R, Vadas MA, et al. Assessing IRES activity in the HIF-1alpha and other cellular 5′ UTRs. RNA 2006;12:1074-83.
28. Dumas E, Staedel C, Colombat M, et al. A promoter activity is present in the DNA sequence corresponding to the hepatitis C virus 5′ UTR. Nucleic Acids Res 2003;31:1275-81.
29. Song Y, Friebe P, Tzima E, et al. The hepatitis C virus RNA 3′-untranslated region strongly enhances translation directed by the internal ribosome entry site. J Virol 2006;80:11579-88.
30. Pedersen IM, Cheng G, Wieland S, et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007;449:919-22.
31. Izumi RE, Das S, Barat B, et al. A peptide from autoantigen LA blocks poliovirus and hepatitis C virus cap-independent translation and reveals a single tyrosine critical for LA RNA binding and translation stimulation. J Virol 2004;78:3763-76.
32. Semler BL, Waterman ML. IRES-mediated pathways to polysomes: nuclear versus cytoplasmic routes. Trends Microbiol 2007;16:1-5.